Rajasthan Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 13-10-2024
- Paid Up Capital ₹ 4.99 Cr
as on 13-10-2024
- Company Age 46 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 47.05 Cr
as on 13-10-2024
- Satisfied Charges ₹ 2.00 Cr
as on 13-10-2024
- Revenue 715.50%
(FY 2021)
- Profit 64.38%
(FY 2021)
- Ebitda 66.10%
(FY 2021)
- Net Worth -10.38%
(FY 2021)
- Total Assets -4.54%
(FY 2021)
About Rajasthan Drugs And Pharmaceuticals
- CIN/LLPIN
U24232RJ1978GOI001823
- Company No.
001823
- Company Classification
Public Limited Union Government Company
- Incorporation Date
02 Nov 1978
- Date of AGM
23 Apr 2024
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- LocationJaipur, Rajasthan
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rajasthan Drugs And Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirja Saraf  | Managing Director | 07-Dec-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunayana Parkash | Director | 07-Feb-2022 | Current |
| Anju Goyal | Nominee Director | 30-Mar-2024 | Current |
| Krishan Gupta | Nominee Director | 11-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Rajasthan Drugs And Pharmaceuticals.
Rajasthan Drugs And Pharmaceuticals Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 715.5% increase. The company also saw a substantial improvement in profitability, with a 64.38% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajasthan Drugs And Pharmaceuticals?
In 2020, Rajasthan Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Karnataka Antibiotics And Pharmaceuticals LimitedActive 43 years 9 monthsNirja Saraf is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 05 Aug 2010 | ₹5.00 Cr | Open |
Bank Of Baroda Creation Date: 16 Aug 2007 | ₹3.00 Cr | Open |
Bank Of Baroda Creation Date: 27 Jan 2006 | ₹3.50 Cr | Open |
How Many Employees Work at Rajasthan Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Rajasthan Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajasthan Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajasthan Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
